Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
dc.contributor.author | Kim, Jae Kwang | |
dc.contributor.author | Park, Sang Un | |
dc.date.accessioned | 2017-05-05T11:38:16Z | |
dc.date.available | 2017-05-05T11:38:16Z | |
dc.date.issued | 2017-01-10 | |
dc.identifier.doi | 10.17179/excli2016-820 | |
dc.identifier.issn | 1611-2156 | |
dc.identifier.uri | http://hdl.handle.net/2003/35956 | |
dc.identifier.uri | http://dx.doi.org/10.17877/DE290R-17979 | |
dc.language.iso | en | |
dc.relation.ispartofseries | EXCLI Journal;Vol. 16 2017 | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.ddc | 610 | |
dc.title | Pharmacological aspects of galantamine for the treatment of Alzheimer's disease | en |
dc.type | Text | |
dc.type.publicationtype | article | |
dcterms.accessRights | open access | |
eldorado.dnb.zdberstkatid | 2132560-1 |